<DOC>
	<DOCNO>NCT00051181</DOCNO>
	<brief_summary>To demonstrate intraocular pressure ( IOP ) -lowering efficacy Travoprost ( 0.004 % ) equal good Latanoprost 0.005 % patient chronic angle-closure glaucoma .</brief_summary>
	<brief_title>A Safety Efficacy Study Travoprost 0.004 % Compared Latanoprost 0.005 % Patients With Chronic Angle-Closure Glaucoma</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Glaucoma , Angle-Closure</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<criteria>Adult patient race either sex chronic angleclosure glaucoma .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Glaucoma</keyword>
	<keyword>POAG</keyword>
	<keyword>OAG</keyword>
	<keyword>OHT</keyword>
</DOC>